Research and development - Articles
In today’s biotech landscape, quality is essential. Good Manufacturing Practice (GMP) guidelines are the cornerstone of safe, effective, and consistent pharmaceutical production. For therapeutics based on peptides or oligonucleotides (TIDES), many of which treat complex or life-threatening conditions, GMP compliance is a foundational element of regulatory approval and patient trust.
Growing Importance of Peptide & Oligonucleotide Therapeutics Peptides and oligonucleotides are transforming modern medicine. Peptide-based drugs have become the fastest-growing segment of chemically synthesized therapeutics, with over 80 approved worldwide, more than 200 in clinical development, and hundreds in preclinical stages (Rossino et al., 2023). Oligonucleotide-based therapies have also seen signi…
Growing Importance of Peptide & Oligonucleotide Therapeutics Peptides and oligonucleotides are transforming modern medicine. Peptide-based drugs have become the fastest-growing segment of chemically synthesized therapeutics, with over 80 approved worldwide, more than 200 in clinical development, and hundreds in preclinical stages (Rossino et al., 2023). Oligonucleotide-based therapies have also seen signi…
The global Clinical Laboratory Services Market is projected to reach USD 453.7 billion by 2033, driven by rising diagnostic demand, automation, and personalized medicine advancements.
The clinical laboratory services market is entering a phase of sustained expansion, fueled by evolving healthcare dynamics, technological advances, and rising demand for diagnostics-led care. According to FutureWise Research, the global clinical laboratory services market is estimated at USD 291.37 billion in 2025, with projections to reach USD 453.7 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.69 % over the forecast period. To Know More: https://www.futurewiseresearch.com/contact.aspx?rpt=9678&type=requestsample This article examines key drivers, segmentation i…
The clinical laboratory services market is entering a phase of sustained expansion, fueled by evolving healthcare dynamics, technological advances, and rising demand for diagnostics-led care. According to FutureWise Research, the global clinical laboratory services market is estimated at USD 291.37 billion in 2025, with projections to reach USD 453.7 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.69 % over the forecast period. To Know More: https://www.futurewiseresearch.com/contact.aspx?rpt=9678&type=requestsample This article examines key drivers, segmentation i…
The global Drug Discovery Services Market is projected to reach USD 68.22 billion by 2033, driven by AI adoption, rising R&D investments, and increased outsourcing in pharmaceutical innovation.
In the rapidly evolving pharmaceutical landscape, drug discovery services have become a pivotal axis around which innovation, efficiency and competitiveness rotate. According to a recent market report by FutureWise, the global Drug Discovery Services Market is projected to grow from US$ 21.4 billion in 2025 to more than US$ 68.22 billion by 2033—signifying a compound annual growth rate (CAGR) of 15.59 %. To Know More: https://www.futurewiseresearch.com/contact.aspx?rpt=3465&type=requestsample This remarkable forecast underscores a confluence of strategic, technological, and market…
In the rapidly evolving pharmaceutical landscape, drug discovery services have become a pivotal axis around which innovation, efficiency and competitiveness rotate. According to a recent market report by FutureWise, the global Drug Discovery Services Market is projected to grow from US$ 21.4 billion in 2025 to more than US$ 68.22 billion by 2033—signifying a compound annual growth rate (CAGR) of 15.59 %. To Know More: https://www.futurewiseresearch.com/contact.aspx?rpt=3465&type=requestsample This remarkable forecast underscores a confluence of strategic, technological, and market…
Histopathological grading examines tissue samples under a microscope to determine the severity of most cancers, and AI can complement human efforts to improve grading. To evaluate AI performance, experts should use a standardized dataset, preprocess AI algorithms against the foundation, and more.
Pharmaceutical experts have been upgrading pathological analysis methods for years. Uncovering secrets under microscopes requires years of training and extensive data, particularly for samples containing cancerous cells. Grading each prognosis demands precision that can be enhanced with the help of artificial intelligence. What Is Histopathological Grading? Histopathological grading examines tissue samples under a microscope to determine the severity of most cancers. It observes trends like c…
Pharmaceutical experts have been upgrading pathological analysis methods for years. Uncovering secrets under microscopes requires years of training and extensive data, particularly for samples containing cancerous cells. Grading each prognosis demands precision that can be enhanced with the help of artificial intelligence. What Is Histopathological Grading? Histopathological grading examines tissue samples under a microscope to determine the severity of most cancers. It observes trends like c…
Artificial intelligence (AI) is rapidly transforming biomarker discovery by unlocking insights from vast and complex datasets. Hurdle recently reviewed how revolutionary this technology could be, while also highlighting the potential hurdles that still stand in the way of its translation into the clinic.
Artificial intelligence (AI) is rapidly transforming biomarker discovery by unlocking insights from vast and complex datasets. Hurdle recently reviewed how revolutionary this technology could be, while also highlighting the potential hurdles that still stand in the way of its translation into the clinic. The Explosion of Data: Bigger, Broader, More ComplexLarge cohort studies are no longer a curiosity; they’re foundational. Crucially, these cohorts increasingly link rich electronic h…
Artificial intelligence (AI) is rapidly transforming biomarker discovery by unlocking insights from vast and complex datasets. Hurdle recently reviewed how revolutionary this technology could be, while also highlighting the potential hurdles that still stand in the way of its translation into the clinic. The Explosion of Data: Bigger, Broader, More ComplexLarge cohort studies are no longer a curiosity; they’re foundational. Crucially, these cohorts increasingly link rich electronic h…
The Bachem team share their insights on the evolving relationship between pharma companies and CDMOs
Outsourcing plays a critical role in modern drug development and manufacturing – one which has gained increasing importance in recent years. The continued rise in demand for complex modalities, such as peptides and oligonucleotides, and increased pressures on time-to-market, have amplified the need for external partnerships and collaboration to ensure supply of crucial medication to patients. As a result, pharmaceutical outsourcing is moving away from transactional, fee-for-service arrangements, toward long-term, strategic partnerships. With a greater need to ensure delivery of medication to patients, industry players are promoting enhanced collaboration, through acknowledging shared goals a…
Outsourcing plays a critical role in modern drug development and manufacturing – one which has gained increasing importance in recent years. The continued rise in demand for complex modalities, such as peptides and oligonucleotides, and increased pressures on time-to-market, have amplified the need for external partnerships and collaboration to ensure supply of crucial medication to patients. As a result, pharmaceutical outsourcing is moving away from transactional, fee-for-service arrangements, toward long-term, strategic partnerships. With a greater need to ensure delivery of medication to patients, industry players are promoting enhanced collaboration, through acknowledging shared goals a…
The global Penicillin Active Pharmaceutical Ingredients (API) market was valued at USD 2.95 billion in 2023 and is projected to reach USD 4.79 billion by 2032, growing at a CAGR of 5.6%. This growth is driven by the increasing demand for antibiotics, advancements in manufacturing technologies, and the expansion of healthcare infrastructure in emerging economies. The report provides an in-depth analysis of market trends, key players, and regional dynamics, offering valuable insights for stakeholders in the pharmaceutical industry.
The Penicillin Active Pharmaceutical Ingredients (APIs) market represents a cornerstone of the global pharmaceutical industry, providing the essential building blocks for antibiotics that combat a wide range of bacterial infections. With its critical role in health…
The Penicillin Active Pharmaceutical Ingredients (APIs) market represents a cornerstone of the global pharmaceutical industry, providing the essential building blocks for antibiotics that combat a wide range of bacterial infections. With its critical role in health…
29-Sep-2025
As cannabis research continues to progress, increasing attention is being given to two promising compounds, cannabigerol (CBG) and its precursor, cannabigerolic acid (CBG-A). Often overshadowed by the more widely recognised cannabinoids THC and CBD, these non-psychoactive compounds are now being explored for their therapeutic potential.
As cannabis research continues to progress, increasing attention is being given to two promising compounds, cannabigerol (CBG) and its precursor, cannabigerolic acid (CBG-A). Often overshadowed by the more widely recognised cannabinoids THC and CBD, these non-psychoactive compounds are now being explored for their therapeutic potential. Broughton, a leading UK-based contract research organisation, explores early research on the potential of these cannabinoid…
As cannabis research continues to progress, increasing attention is being given to two promising compounds, cannabigerol (CBG) and its precursor, cannabigerolic acid (CBG-A). Often overshadowed by the more widely recognised cannabinoids THC and CBD, these non-psychoactive compounds are now being explored for their therapeutic potential. Broughton, a leading UK-based contract research organisation, explores early research on the potential of these cannabinoid…
The global Ambulatory EHR Market is projected to grow from USD 6.1 billion in 2023 to USD 10.5 billion by 2032 at a CAGR of 6.3%. Explore market size, major regional trends, deployment shifts toward cloud/web-based models, leading vendors, and what to expect through 2032 in this comprehensive analysis guided by Ameco Research.
In recent years, the healthcare industry has undergone rapid digital transformation. Among its key components is the adoption of Ambulatory EHR (Electronic Health Records in outpatient / ambulatory care settings) systems. These solutions are essential tools for physician offices, specialty clinics, and other outpatient facilities to maintain accurate patient histories, manage clinical workflows, enable remote care protocols, and meet regulatory requirements. As pressu…
In recent years, the healthcare industry has undergone rapid digital transformation. Among its key components is the adoption of Ambulatory EHR (Electronic Health Records in outpatient / ambulatory care settings) systems. These solutions are essential tools for physician offices, specialty clinics, and other outpatient facilities to maintain accurate patient histories, manage clinical workflows, enable remote care protocols, and meet regulatory requirements. As pressu…
Multiple System Atrophy Therapeutics is an evolving field focused on treating a rare neurodegenerative disease with no cure. This article examines the Multiple System Atrophy Therapeutics Market, its size, growth drivers, recent product development, regional trends, key players, and what lies ahead up to 2033—based largely on the report by Acumen Research And Consulting.
What is Multiple System Atrophy and the Role of Therapeutics Multiple System Atrophy (MSA) is a progressive, rare neurodegenerative disorder adversely affecting the autonomic nervous system, movement, balance, coordination, and various bodily functions. Patients experience tremor, parkinsonian symptoms, cerebellar dysfunction, autonomic dysregulation (blood pressure, bladder control), and rapidly declining ability to perfor…
What is Multiple System Atrophy and the Role of Therapeutics Multiple System Atrophy (MSA) is a progressive, rare neurodegenerative disorder adversely affecting the autonomic nervous system, movement, balance, coordination, and various bodily functions. Patients experience tremor, parkinsonian symptoms, cerebellar dysfunction, autonomic dysregulation (blood pressure, bladder control), and rapidly declining ability to perfor…
The CBH Biospecimen Marketplace is an online biobank and biorepository built for teams who need human biological samples with audit-ready documentation and dependable logistics. Our continuously curated biological specimen inventory exceeds a quarter of a million active units and spans serum, plasma, whole blood, PBMC for research, urine samples, cerebrospinal fluid (CSF), saliva, stool/feces/faeces, swab samples, and human tissue (FFPE and frozen). You can search, filter, compare, and order human biospecimens for research, development, and production—not only RUO feasibility. What differentiates the platform is scientific traceability: standardized preanalytics, transparent biospecimen data, and route-proven cold-chain shipping.
What Counts as a Human Biological Specimen? Human biol…
What Counts as a Human Biological Specimen? Human biol…
Nutrigenomics is reshaping how we understand the connection between genes and diet. This article explores how DNA insights can guide personalized nutrition, improve long-term wellness strategies, and empower individuals to make informed lifestyle choices. With privacy-first, on-device processing, Noorns provides a secure and innovative approach to DNA-based health insights, bridging science and everyday health.
Nutrigenomics, the study of how our genes interact with diet, is emerging as one of the most promising areas in personalized health. Genetic variations can influence how we metabolize nutrients, respond to supplements, and manage risks for chronic conditions. Understanding these patterns opens new opportunities for preventative care, optimized wellness strategies, and more targeted i…
Nutrigenomics, the study of how our genes interact with diet, is emerging as one of the most promising areas in personalized health. Genetic variations can influence how we metabolize nutrients, respond to supplements, and manage risks for chronic conditions. Understanding these patterns opens new opportunities for preventative care, optimized wellness strategies, and more targeted i…
Analytical method development and validation are essential for CRDMO success, ensuring accurate, reliable, and regulatory-compliant results from R&D to GMP manufacturing. Pharmaffiliates integrates ISO 17025-accredited lab services into its CRDMO model, offering capabilities like HPLC, LC-MS/MS, impurity profiling, stability testing, and method transfer. Validated methods enable consistent batch quality, faster scale-up, and streamlined regulatory compliance, helping clients accelerate drug development with confidence.
The Role of Analytical Method Development in CRDMO Success Why Analytics Is a Pillar of Pharmaceutical Development In today’s pharmaceutical environment, where compliance and speed-to-market are paramount, analytical method development and validation play a foun…
The Role of Analytical Method Development in CRDMO Success Why Analytics Is a Pillar of Pharmaceutical Development In today’s pharmaceutical environment, where compliance and speed-to-market are paramount, analytical method development and validation play a foun…
The United States Food and Drug Administration’s (FDA’s) Accelerated Approval (AA) pathway, initially established in 1992 during the HIV/AIDS epidemic to provide faster access to life-saving treatments, has been instrumental in expediting access to therapies for serious and life-threatening conditions. It is particularly significant in therapeutic areas, such as rare diseases, where surrogate or intermediate clinical endpoints may be necessary due to limited patient populations or slow disease progression. While this approach has encouraged innovation, it has also raised concerns about drugs staying on the market without confirmed evidence of their effectiveness.
The United States Food and Drug Administration’s (FDA’s) Accelerated Approval (AA) pathway, initially established in 1992 during…
The United States Food and Drug Administration’s (FDA’s) Accelerated Approval (AA) pathway, initially established in 1992 during…
12-Aug-2025
Hackers know pharmaceutical robots are a lucrative avenue for priceless data. Pharmacies and hospitals must collaborate with manufacturers and analysts to formulate the most future-proof plans for medical robots. Communication will be the key to robust pharmaceutical tools that withstand any incoming onslaught from cybercriminals.
The medical sector has interwoven robotics into surgeries and research for decades, but they are becoming more essential and connected. From sensors to artificial intelligence capabilities, the amount of data and sensitive information they contain is a prime target for threat actors. Manufacturers and medical professionals must collaborate to create safe pharmaceutical robots to protect patients. Fortunately, many resources exist to combat concerns. How Are Robots…
The medical sector has interwoven robotics into surgeries and research for decades, but they are becoming more essential and connected. From sensors to artificial intelligence capabilities, the amount of data and sensitive information they contain is a prime target for threat actors. Manufacturers and medical professionals must collaborate to create safe pharmaceutical robots to protect patients. Fortunately, many resources exist to combat concerns. How Are Robots…
08-Aug-2025
From sequence to 30 L and manufacturing scale, why outsourcing saves resources in the long run and makes economic sense.
Isomerase is a leading bioprocessing company that offers partners the ability to scale up their processes or projects from the lab to industrial manufacturing. Partners from various industries, including pharma, biotech, as well as food and ingredients, opt to work with our bioprocessing services when scaling. In this article, we provide an overview of what we offer, enabling you to make an informed decision when considering outsourcing. What is microbial bioprocessing? Once a microbe and the product of interest have been optimised, by engineering the production strain and/or target sequence, the process needs to be scaled. Generating such a product within a livin…
Isomerase is a leading bioprocessing company that offers partners the ability to scale up their processes or projects from the lab to industrial manufacturing. Partners from various industries, including pharma, biotech, as well as food and ingredients, opt to work with our bioprocessing services when scaling. In this article, we provide an overview of what we offer, enabling you to make an informed decision when considering outsourcing. What is microbial bioprocessing? Once a microbe and the product of interest have been optimised, by engineering the production strain and/or target sequence, the process needs to be scaled. Generating such a product within a livin…
o2h Discovery has launched the Peptide Guarantee Programme, with the aim to deliver custom linear peptides (≥95% purity, ≤20 amino acids) in 2 weeks from project initiation, complete with HPLC, MS, and Certificate of Analysis. If it’s delayed, it’s on us.
Peptides have emerged as indispensable tools in modern drug discovery, playing a central role in areas such as oncology, metabolic disorders, targeted delivery, and protein–protein interaction modulation. With over 80 peptide-based drugs approved globally and hundreds more in clinical pipelines, the demand for reliable, scalable, and fast Custom Peptide Synthesis services has never been greater (Source 1). Their unique ability to precisely modulate biological pathways has driven rapid market expansion: from around $50 billion in g…
Peptides have emerged as indispensable tools in modern drug discovery, playing a central role in areas such as oncology, metabolic disorders, targeted delivery, and protein–protein interaction modulation. With over 80 peptide-based drugs approved globally and hundreds more in clinical pipelines, the demand for reliable, scalable, and fast Custom Peptide Synthesis services has never been greater (Source 1). Their unique ability to precisely modulate biological pathways has driven rapid market expansion: from around $50 billion in g…
The intimate wash care products industry is projected to grow steadily through 2032, driven by changing hygiene standards, rising awareness, and evolving consumer preferences. Explore trends, market share insights, and growth drivers.
In recent years, the global health and wellness industry has seen an unprecedented evolution—not only in mainstream personal care but also in intimate hygiene. Among the most dynamic and increasingly visible segments is the intimate wash care products category, which has transitioned from niche awareness to everyday consumer routines in many parts of the world. As per data released by Acumen Research and Consulting, the global intimate wash care product market was valued at USD 28.6 billion in 2023 and is projected to reach USD 45.9 billion by 2032, expanding…
In recent years, the global health and wellness industry has seen an unprecedented evolution—not only in mainstream personal care but also in intimate hygiene. Among the most dynamic and increasingly visible segments is the intimate wash care products category, which has transitioned from niche awareness to everyday consumer routines in many parts of the world. As per data released by Acumen Research and Consulting, the global intimate wash care product market was valued at USD 28.6 billion in 2023 and is projected to reach USD 45.9 billion by 2032, expanding…
Examine the Regenerative Medicine Scaffolds Market growth—from USD 336.5 Million in 2023 to USD 1.72 Billion by 2032 at a 20.2% CAGR. Learn key trends, technology advances, regional dynamics, and tissue repair innovations reshaping healthcare.
Biomaterials engineered to restore, replace, or augment damaged tissues are gaining momentum—and at the core are Regenerative Medicine Scaffolds, critical in advancing tissue repair across orthopedics, neurology, wound healing, and cardiovascular applications. Our recent analysis at Acumen Research & Consulting sheds light on shifting market dynamics, emerging technologies, and region-wise growth projections. Market Size & Growth Outlook The Regenerative Medicine Scaffolds Market Size reached USD 336.5 million in 2023 and is forecast to so…
Biomaterials engineered to restore, replace, or augment damaged tissues are gaining momentum—and at the core are Regenerative Medicine Scaffolds, critical in advancing tissue repair across orthopedics, neurology, wound healing, and cardiovascular applications. Our recent analysis at Acumen Research & Consulting sheds light on shifting market dynamics, emerging technologies, and region-wise growth projections. Market Size & Growth Outlook The Regenerative Medicine Scaffolds Market Size reached USD 336.5 million in 2023 and is forecast to so…
Explore the top companies by revenue in the breast biopsy devices market, segmented by tiers. Discover key trends, growth drivers, and market projections through 2033
The breast biopsy devices market is witnessing significant growth, propelled by the increasing global prevalence of breast cancer, advancements in diagnostic imaging technologies, and growing awareness of early cancer detection. As of 2025, the market is estimated to be worth $2.18 billion, and it is expected to reach $3.8 billion by 2033, growing at a CAGR of 6.3%. In this article, we highlight the top companies by revenue, explore key market segments, and examine the strategic trends shaping the future of breast cancer diagnostics. Request Sample Pages: https://www.regalintel…
The breast biopsy devices market is witnessing significant growth, propelled by the increasing global prevalence of breast cancer, advancements in diagnostic imaging technologies, and growing awareness of early cancer detection. As of 2025, the market is estimated to be worth $2.18 billion, and it is expected to reach $3.8 billion by 2033, growing at a CAGR of 6.3%. In this article, we highlight the top companies by revenue, explore key market segments, and examine the strategic trends shaping the future of breast cancer diagnostics. Request Sample Pages: https://www.regalintel…
